Live biotherapeutic products (LBPs) have been hailed as the answer for patients suffering from Irritable Bowel Syndrome (IBS), says GlobalData, which cite a lack of defined regulations as the main barrier to progress.
March 2021. With signs of lockdown coming to an end, thoughts naturally turn to missed career opportunities and setting plans into motion. Here, NutraIngredients rounds up Feb’s movers and shakers.
Biotherapeutics firm 4D pharma announces a collaboration with Merck & Co (MSD) in a deal that looks to develop vaccines that deliver live bacteria to the gut.
